These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8183585)
1. [Local microviscosity of platelet membranes from patients with chronic renal failure on hemodialysis]. Rud'ko IA; Chebotarev VN; Kubatiev AA Patol Fiziol Eksp Ter; 1994; (1):20-2. PubMed ID: 8183585 [TBL] [Abstract][Full Text] [Related]
2. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation. Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892 [TBL] [Abstract][Full Text] [Related]
3. Platelet function in patients on long term peritoneal dialysis. Lindsay RM; Friesen M; Koens F; Linton AL; Oreopoulos D; de Veber G Clin Nephrol; 1976 Aug; 6(2):335-9. PubMed ID: 954241 [TBL] [Abstract][Full Text] [Related]
4. [The morphofunctional damage to the biomembranes in the lipid peroxidation syndrome in patients with the terminal stage of chronic kidney failure]. Grinshteĭn IuI; Linev KA Urol Nefrol (Mosk); 1989; (6):45-8. PubMed ID: 2617738 [TBL] [Abstract][Full Text] [Related]
5. [The effect of hemodialysis on the level of cytoplasmic Ca2+ in the thrombocytes of patients with chronic kidney failure]. Rud'ko IA; Kubatiev AA; Tsalenchuk IaP Urol Nefrol (Mosk); 1993; (4):37-9. PubMed ID: 8310566 [TBL] [Abstract][Full Text] [Related]
6. [The effect of hemodialysis on lipid peroxidation]. Stetsiuk EA; Khokhlov AP; Siniukhin VN; Ivanov VE; Iarmolinskiĭ IS Urol Nefrol (Mosk); 1989; (4):47-50. PubMed ID: 2800078 [TBL] [Abstract][Full Text] [Related]
7. [Influence of hemodialysis on expression of glycoprotein lb platelets reactivity in patients with the end stage renal failure]. Brzósko S; Hryszko T; Zak J; Wysocka J; Małyszko J; Myśliwiec M Przegl Lek; 2002; 59(10):823-5. PubMed ID: 12632921 [TBL] [Abstract][Full Text] [Related]
8. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients. Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905 [TBL] [Abstract][Full Text] [Related]
9. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316 [TBL] [Abstract][Full Text] [Related]
10. [Blood platelet function in chronic renal insufficiency and the influence of hemodialysis]. Cepelák V; Prokop J; Petrlík M Vnitr Lek; 1974 Jul; 20(6):528-38. PubMed ID: 4844787 [No Abstract] [Full Text] [Related]
11. [The effect of recombinant human erythropoietin during hemodialysis on the thrombocyte and erythrocyte functions of patients with chronic kidney failure]. Rud'ko IA; Balashova TS; Kubatiev AA; Ermolenko VM Ter Arkh; 1994; 66(6):57-60. PubMed ID: 7940371 [TBL] [Abstract][Full Text] [Related]
12. [Changes in the lipid content of erythrocytes in patients with chronic renal failure]. Witkowska J; Bober J; Chlubek D Ann Acad Med Stetin; 2007; 53(2):46-51. PubMed ID: 18557376 [TBL] [Abstract][Full Text] [Related]
13. [The influence of recombinant human erythropoietin on platelet phospholipid fatty acid composition in patients on long term hemodialysis]. Krawczyk W; Dmoszyńska A; Ledwozyw A Pol Merkur Lekarski; 1996 Dec; 1(6):394-7. PubMed ID: 9273229 [TBL] [Abstract][Full Text] [Related]
14. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study. Diop ME; Viron B; Bailleul S; Lefevre G; Fessi H; Maury J; Etienne J; Couderc R Clin Nephrol; 2000 Sep; 54(3):210-7. PubMed ID: 11020019 [TBL] [Abstract][Full Text] [Related]
15. Effect of two different dialysis membranes on leukocyte adhesion and aggregation. Hernandez MR; Palomo M; Fuste B; Carbó C; Collado S; Cases A; Escolar G Nephron Clin Pract; 2007; 106(1):c1-8. PubMed ID: 17347577 [TBL] [Abstract][Full Text] [Related]
16. Hemostatic changes in patients with end stage renal disease undergoing hemodialysis. Rios DR; Carvalho Md; Lwaleed BA; Simões e Silva AC; Borges KB; Dusse LM Clin Chim Acta; 2010 Feb; 411(3-4):135-9. PubMed ID: 19945449 [TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of neuropeptide and neurotensin in the extract of platelet of chronic renal failure patients during hemodialysis]. Luo N; Meng J; Yang D; Wu C; Qi F; Kong L; Liu W Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1999 Sep; 16(3):362-4, 381. PubMed ID: 12552763 [TBL] [Abstract][Full Text] [Related]
18. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis]. Miler M; Zamojska S; Fijałkowski P; Lobos M; Paradowski MT Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263 [TBL] [Abstract][Full Text] [Related]
19. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196 [TBL] [Abstract][Full Text] [Related]
20. [Changes in platelets, coagulation and fibrinolysis in patients with chronic kidney diseases and hemodialysis]. Terada H Nihon Rinsho; 1992 Jan; 50 Suppl():565-72. PubMed ID: 1578739 [No Abstract] [Full Text] [Related] [Next] [New Search]